Product Images Xenpozyme
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Xenpozyme NDC 58468-0051 by Genzyme Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - xenpozyme 01
This appears to be a table showing the number of patients who were given either a placebo or a medication called XENPOZYME (which appears to be spelled out in capital letters) over a period of 104 weeks. The table contains columns for each of the five time points (Baseline, Week26, Week52, Week80, and Week104) and rows for each group of patients (those given placebo, and those given XENPOZYME). The number of patients in each group is shown for each time point. The meaning or context for the numbers is not clear.*
Figure 2 - xenpozyme 02
PRINCIPAL DISPLAY PANEL - 20 mg Vial Carton - xenpozyme 03
This is a description of Menpozyme™, which is a medication that is administered by injection. Each vial of Menpozyme™ contains 20 mg of olipudase alfa-rpcp and is reconstituted with 5.1 mL of sterile water for injection, USP to a single-dose solution. It is manufactured by Genzyme Corporation and is stored refrigerated. For more information on dosage and storage, see prescribing information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.